Cargando…
Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis
OBJECTIVE: Genetic factors predisposing to late‐onset myasthenia gravis (LOMG) have not been clearly defined yet. However, genome‐wide association studies identified Human Leukocyte Antigen (HLA) Class II alleles as a hotspot in this disease subtype. The aim of this study was to analyze the correlat...
Autores principales: | Spagni, Gregorio, Todi, Laura, Monte, Gabriele, Valentini, Mariagrazia, Di Sante, Gabriele, Damato, Valentina, Marino, Mariapaola, Evoli, Amelia, Lantieri, Francesca, Provenzano, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951107/ https://www.ncbi.nlm.nih.gov/pubmed/33547763 http://dx.doi.org/10.1002/acn3.51309 |
Ejemplares similares
-
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis
por: Marino, Mariapaola, et al.
Publicado: (2020) -
Safety and tolerability of SARS‐Cov‐2 vaccination in patients with myasthenia gravis: A multicenter experience
por: Farina, Antonio, et al.
Publicado: (2022) -
Immunological response after SARS-CoV-2 infection and mRNA vaccines in patients with myasthenia gravis treated with Rituximab
por: Damato, Valentina, et al.
Publicado: (2023) -
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients
por: Basile, Umberto, et al.
Publicado: (2018) -
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia Gravis
por: Spagni, Gregorio, et al.
Publicado: (2022)